Rechallenge of BRAF +/- MEK Inhibitors Following an Adverse Event in Patients With Cancer

计划入组 16,000 人 · 首次发布于 2021 年 10 月 15 日

A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy

计划入组 26 人 · 首次发布于 2012 年 8 月 17 日

Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors

计划入组 19 人 · 首次发布于 2014 年 12 月 9 日

Dimethyl Sulfoxide(Rimso-50)

C₂H₆OS

ERK1/2 inhibitors (Celgene)

serum and glucocorticoid-regulated kinase-1 inhibitors (Visionary)

Gene Signal SAS

France

BIO-SIGNAL GROUP CORP.

United States

Green Signal Biopharma Private Limited

BioVie to Host Investor Webinar on November 7th, 2024, to Discuss Clinical Programs

BioVie's Bezisterim to Enter Phase 2 Trial for Long COVID Treatment

FDA Approves Digital Therapeutic for GAD, Updated Novavax COVID-19 Vaccine, and New Insulin Patch Pump